In addition, previous studies have shown that visfatin/NAMPT concentrations are increased in several malignancies, such as colorectal carcinoma, gastric cancer, hepatocellular carcinoma, bladder cancer, breast cancer, endometrial cancer, and other carcinomas [16,24,25,26,27,28]. Here, NAMPT is linked to urinary bladder cancer.